High materiality7/10
BridgeBio Pharma price target raised to $120 from $115 at Piper Sandler
Why it may matterVerify against the original reporting
buy
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
BBIO price target raised to $120 by Piper Sandler; current price $66.39.
- Target raised to $120; price ~$66.39.
Key facts
- 01
Target: $120
- 02
Posted price: $66.39
- 03
Analyst firm: Piper Sandler
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.